Mona Abaoui
3001, 12th Avenue North
Sherbrooke, QC J1H5N4, Canada
Sherbrooke, QC J1H5N4, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Diurnal Variation of Urinary Fabry Disease Biomarkers during Enzyme Replacement Therapy Cycles.
Journal: International journal of molecular sciences
Published: July 24, 2020
Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort.
Journal: Journal of medical genetics
Published: May 04, 2020
High-risk screening for Fabry disease in a Canadian cohort of chronic kidney disease patients.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: August 22, 2019
Altered immune phenotypes in subjects with Fabry disease and responses to switching from agalsidase alfa to agalsidase beta.
Journal: American journal of translational research
Published: June 06, 2018
Analysis of globotriaosylceramide (Gb3) isoforms/analogs in unfractionated leukocytes, B lymphocytes and monocytes from Fabry patients using ultra-high performance liquid chromatography/tandem mass spectrometry.
Journal: Analytica chimica acta
Published: September 24, 2017
High-Risk Screening for Fabry Disease: Analysis by Tandem Mass Spectrometry of Globotriaosylceramide (Gb3 ) in Urine Collected on Filter Paper.
Journal: Current protocols in human genetics
Published: April 07, 2017
Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34+ Cells for Correction of Fabry Disease.
Journal: Molecular therapy. Methods & clinical development
Published: January 20, 2017
High-Risk Screening of Fabry Disease: Analysis of Fifteen Urinary Methylated and Non-Methylated Gb3 Isoforms Using Tandem Mass Spectrometry.
Journal: Current protocols in human genetics
Published: October 12, 2016
Tandem Mass Spectrometry Quantitation of Lyso-Gb3 and Six Related Analogs in Plasma for Fabry Disease Patients.
Journal: Current protocols in human genetics
Published: July 02, 2016
Fabry Disease Biomarkers: Analysis of Urinary Lyso-Gb3 and Seven Related Analogs Using Tandem Mass Spectrometry.
Journal: Current protocols in human genetics
Published: July 02, 2016
Tandem mass spectrometry multiplex analysis of methylated and non-methylated urinary Gb3 isoforms in Fabry disease patients.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: June 28, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026